 The treatment regimen combines three drugs from at least two different classes of antiretroviral drugs.The advance of etravirine over other NNRTIs is that multiple mutations are required for the development of drug resistance.The drug has also shown activity against viruses with common NNRTI resistance associated mutations and cross-resistance mutations.